Hai‐Yu Mo

1.2k total citations
13 papers, 513 citations indexed

About

Hai‐Yu Mo is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Hai‐Yu Mo has authored 13 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Hai‐Yu Mo's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Immune cells in cancer (3 papers). Hai‐Yu Mo is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Immune cells in cancer (3 papers). Hai‐Yu Mo collaborates with scholars based in China, United States and Hong Kong. Hai‐Yu Mo's co-authors include Huai‐Qiang Ju, Rui‐Hua Xu, Kun Liao, Ting Li, Qi‐Nian Wu, Xiaojun Zheng, Hui Sheng, Yan‐Xing Chen, Zhao-Lei Zeng and Hai‐long Piao and has published in prestigious journals such as Nature Communications, Molecular Cell and Cancer Research.

In The Last Decade

Hai‐Yu Mo

12 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hai‐Yu Mo China 9 350 239 95 74 71 13 513
Pei-Qi Huang China 12 195 0.6× 124 0.5× 120 1.3× 119 1.6× 62 0.9× 22 432
Christoph Wohlkoenig Austria 7 281 0.8× 189 0.8× 80 0.8× 44 0.6× 65 0.9× 9 413
Zhi Xu China 8 243 0.7× 196 0.8× 88 0.9× 66 0.9× 25 0.4× 14 419
Fengqing Fu China 11 260 0.7× 196 0.8× 195 2.1× 165 2.2× 46 0.6× 27 516
Xue Guan China 17 610 1.7× 493 2.1× 50 0.5× 64 0.9× 67 0.9× 29 757
Can Lu China 12 211 0.6× 103 0.4× 95 1.0× 54 0.7× 58 0.8× 22 375
Kristina Diepold Germany 6 267 0.8× 222 0.9× 67 0.7× 51 0.7× 30 0.4× 6 404

Countries citing papers authored by Hai‐Yu Mo

Since Specialization
Citations

This map shows the geographic impact of Hai‐Yu Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai‐Yu Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai‐Yu Mo more than expected).

Fields of papers citing papers by Hai‐Yu Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai‐Yu Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai‐Yu Mo. The network helps show where Hai‐Yu Mo may publish in the future.

Co-authorship network of co-authors of Hai‐Yu Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Hai‐Yu Mo. A scholar is included among the top collaborators of Hai‐Yu Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai‐Yu Mo. Hai‐Yu Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Chen, Wei, Hui Sheng, Hai‐Yu Mo, et al.. (2026). The AHCY–adenosine complex rewires mRNA methylation to enhance fatty acid biosynthesis and tumorigenesis. Cell Research. 36(2). 152–172.
2.
Lin, Jin‐Fei, Zexian Liu, Dongliang Chen, et al.. (2025). Nucleus-translocated GCLM promotes chemoresistance in colorectal cancer through a moonlighting function. Nature Communications. 16(1). 263–263. 4 indexed citations
3.
Cai, Zerong, Di Chen, Haojie Chen, et al.. (2024). Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprints. EMBO Molecular Medicine. 16(12). 3089–3112. 5 indexed citations
5.
Mo, Hai‐Yu, Mengyao Ma, Yi Zhang, et al.. (2024). MTHFD2-mediated redox homeostasis promotes gastric cancer progression under hypoxic conditions. Redox Report. 29(1). 2345455–2345455. 11 indexed citations
6.
Tian, Tian, Yongqiang Zheng, Hai‐Yu Mo, et al.. (2023). The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer. Nature Communications. 14(1). 6690–6690. 44 indexed citations
7.
Guo, Zeyi, Qingyu Xie, Yanping Wu, et al.. (2023). Aberrant expression of circular RNA DHPR facilitates tumor growth and metastasis by regulating the RASGEF1B/RAS/MAPK axis in hepatocellular carcinoma. Cellular Oncology. 46(5). 1333–1350. 10 indexed citations
8.
Han, Yi, Yanyu Zhang, Xiaojun Zheng, et al.. (2023). IL-1β-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance. Molecular Cell. 83(11). 1887–1902.e8. 73 indexed citations
9.
Liu, Zexian, Zhao-Lei Zeng, Xiao-Jing Luo, et al.. (2022). The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer. Cancer Research. 83(9). 1476–1489. 37 indexed citations
10.
Li, Ting, Yan‐Xing Chen, Xiaojun Zheng, et al.. (2022). Methionine deficiency facilitates antitumour immunity by altering m6A methylation of immune checkpoint transcripts. Gut. 72(3). 501–511. 135 indexed citations
11.
Zeng, Zhao-Lei, Jia-Huan Lu, Yun Wang, et al.. (2021). The lncRNA XIST/miR‐125b‐2‐3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer. Cancer Medicine. 10(7). 2423–2441. 30 indexed citations
12.
Ju, Huai‐Qiang, Qi Zhao, Feng Wang, et al.. (2019). A circRNA signature predicts postoperative recurrence in stage II/III colon cancer. EMBO Molecular Medicine. 11(10). e10168–e10168. 101 indexed citations
13.
Ju, Huai‐Qiang, Hao Li, Tian Tian, et al.. (2015). Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor‐κB activation. Journal of Pineal Research. 60(1). 27–38. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026